Please assess the completion status of the following clinical trial:

Trial Title: Chemoradiation +Gemcitabine +Continuous 5-FU (Fluorouracil) Followed by High Dose Brachytherapy/Stereotactic Radiation Boost in Locally Advanced Intra/Extrahepatic Cholangiocarcinoma

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Patients over age 18~2. Intra or extrahepatic cholangiocarcinoma confirmed by biopsy/brushings, biliary aneuploidy demonstrated by FISH, or elevated CA 19-9 greater than 100 ng/mL in the presence of a radiographic malignant stricture~3. Deemed surgically unresectable by a surgical oncologist~4. Malignant disease encompassable within a single radiation field~5. ECOG 0-2~6. Laboratory values: Hemoglobin ≥ 8.0 (can be transfused to attain this value), Granulocytes \> 1,500, platelets \> 100,000/ul~Exclusion Criteria:~1. Chemotherapy within one month of starting radiation therapy~2. Previous abdominal radiotherapy~3. Uncontrolled infection or severe active comorbid disease~4. Previous malignancy in the past five years, excluding nonmelanoma skin cancers and in situ cervical, bladder or uterine cancer~5. Distant metastatic disease (outside regional lymph nodes)~6. Pregnancy or lactating women

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- All patients (Type: EXPERIMENTAL): All participants enrolled.

Based on this trial design, predict the completion outcome and termination type (if applicable).